Perspective Therapeutics Inc.

Healthcare · Medical Devices

2.50$ +0.8% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Perspective Therapeutics Inc. (CATX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 392 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CATX
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	20	18	17	15	14	12	11	9.4	8.3	7.5	13	12	11	9.4	10	8.9	9.0	8.7	8.0	16	71	70	66	64	63	58	128	120	111	98	278	386	391	341	329	311	295	267	411	392
Current Assets	13	14	15	13	12	10	8.9	7.4	6.3	5.5	11	9.8	8.4	7.3	6.8	5.6	5.7	5.5	4.7	12	68	67	63	59	58	53	40	32	22	17	188	294	270	231	216	196	179	148	275	242
Cash	5.7	10	8.5	6.7	5.1	5.9	4.0	3.0	2.4	2.6	2.2	3.2	4.1	5.3	4.6	3.2	2.4	2.4	1.9	9.6	65	64	59	56	19	21	36	28	18	9.2	142	252	226	62	44	29	27	31	54	48
Cash & Short-Term Investments	12	12	14	12	10	9.0	7.3	5.7	4.5	3.4	9.2	7.9	6.4	5.3	4.6	3.2	2.4	2.4	1.9	9.6	65	64	59	56	54	44	36	28	18	9.2	181	293	268	227	212	192	174	145	271	237
Receivables	0.9	0.6	0.6	0.6	0.9	0.7	0.7	1.0	1.0	1.2	1.1	1.1	1.1	1.2	1.5	1.4	2.1	2.1	1.8	1.7	2.0	2.0	2.1	1.6	1.2	1.4	1.4	1.1	1.7	1.2	1.0	0.1	0.2	1.5	0.1	0.2	0.2	1.0	0.1	0.3
Inventory	0.5	0.3	0.4	0.4	0.3	0.3	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.6	0.6	0.6	0.7	0.7	1.0	1.2	1.4	1.6	1.6	1.4	1.1	1.0	–	–	–	–	-1.4	–	–	–	–	–	–
Property, Plant & Equipment	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	2.4	2.3	7.0	7.8	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	27	27	27	24	24	24	24	0.0	–	–	–	–	–	–
Intangible Assets	–	0.2	–	0.2	–	0.2	–	0.2	–	0.2	–	0.2	–	0.2	–	0.1	–	0.1	–	0.1	0.1	0.1	0.1	0.1	0.1	0.0	50	50	50	50	50	50	50	50	50	50	50	40	40	40
Total Liabilities	2.3	1.7	1.7	1.4	1.7	1.7	1.6	1.5	1.7	2.4	2.2	2.2	2.0	1.7	3.2	2.8	3.1	3.0	2.9	2.7	3.2	3.0	2.9	3.2	4.8	3.4	9.6	11	12	23	48	45	63	50	45	45	53	60	63	68
Current Liabilities	1.2	1.1	1.1	0.9	1.1	1.1	1.1	0.9	1.1	1.8	1.6	1.6	1.4	1.1	1.7	1.3	1.7	1.6	1.5	1.3	1.9	1.8	2.0	2.3	4.0	3.1	7.2	8.6	8.1	16	15	11	28	18	13	13	21	29	31	37
Short-Term Debt	–	–	–	–	–	–	–	–	–	–	–	–	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.3	0.3	0.3	0.3	0.4	0.3	0.3	0.1	0.2	0.8	1.0	1.0	1.0	0.9	0.8	0.7	1.1	1.2
Accounts Payable	0.7	0.6	0.5	0.3	0.7	0.6	0.8	0.6	0.8	1.4	1.2	1.2	1.0	0.7	1.0	0.6	0.9	0.7	0.8	0.5	1.0	0.7	0.8	1.0	2.5	1.5	3.9	4.9	3.9	6.9	6.0	6.1	22	10	8.7	7.0	13	21	26	29
Long-Term Debt	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1.7	1.7	1.7	1.7	1.7	1.7	1.6	1.6	1.6	1.6	1.6	1.6	1.6	1.5
Shareholders' Equity	18	16	15	14	12	11	9.1	7.9	6.6	5.0	11	9.7	8.6	7.7	7.0	6.1	5.8	5.7	5.1	13	68	67	63	61	58	55	118	109	99	75	230	341	328	291	285	266	242	207	347	324
Retained Earnings	-65	-66	-68	-69	-71	-73	-74	-76	-77	-79	-81	-82	-83	-84	-85	-86	-87	-88	-89	-90	-90	-91	-97	-99	-103	-106	-106	-117	-128	-152	-165	-176	-192	-232	-250	-271	-297	-335	-361	-388
Shares Outstanding	55	55	55	55	55	55	55	55	55	55	66	67	67	67	67	67	37	6.8	6.9	8.3	12	14	14	14	23	28	23	28	28	67	28	50	71	2.1	71	71	74	74	74	74

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings